Cite
HARVARD Citation
Wang, X. et al. (n.d.). Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial. European journal of surgical oncology. 41 (8), pp. 1082-1088. [Online].